Cowen Downgrades Complete Genomic (GNOM) to Neutral
Tweet
Share
E-mailGet Alerts GNOM Hot Sheet
Price: $56.65 -3.23%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Join SI Premium – FREE
Cowen downgraded Complete Genomic (NASDAQ: GNOM) from Outperform to Neutral.
For more ratings news on Complete Genomic click here and for the rating history of Complete Genomic click here.
Shares of Complete Genomic closed at $17.11 yesterday.
For more ratings news on Complete Genomic click here and for the rating history of Complete Genomic click here.
Shares of Complete Genomic closed at $17.11 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CSX (CSX) PT Raised to $46 at TD Cowen
- Morgan Stanley Downgrades Zhongsheng Group Holdings (881:HK) (ZSHGY) to Equalweight
- Deutsche Bank Downgrades Bytes Technology Group PLC (BYIT:LN) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
